ClinicalTrials.Veeva

Menu

Termination of Early Pregnancy in Scarred Uterus With Lletrozole and Misoprostol Compared to Misoprostol Alone

A

Ahmed Elsayed Aref

Status

Unknown

Conditions

Termination of Early Pregnancy in Scarred Uterus

Treatments

Drug: Letrozole 2.5mg

Study type

Observational

Funder types

Other

Identifiers

NCT05067309
Soh-Med-21-09-07

Details and patient eligibility

About

Termination of early pregnancy in scarred uterus with letrozole and misoprostol compared to Misoprostol alone

Enrollment

1 estimated patient

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Minimum age of 18 years for mother.

    • Non-viable fetus (missed abortion or blighted ovum) in the 1st trimester of pregnancy evidenced by criteria for diagnosis by TVS .
    • Previous C.S or Myomectomy (1 or more )
    • lack of any maternal diseases such as: heart disease, asthma, history of thromboembolism, cancer, renal failure, and liver diseases.

Exclusion criteria

  • * Medical problem in patient

    • Emergency conditions which need intervention .
    • History of allergy to misoprostol or letrozole drugs.

Trial design

1 participants in 2 patient groups

Missed abortion received letrozole then misoprostol
Treatment:
Drug: Letrozole 2.5mg
Missed abortion received misoprostol alone

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems